His primary areas of investigation include Virology, Immunology, Cytotoxic T cell, CTL* and CD8. His work deals with themes such as Epitope, Antibody and Immune system, which intersect with Virology. His research on Immunology often connects related topics like Protease inhibitor.
His work is dedicated to discovering how Cytotoxic T cell, Molecular biology are connected with Chemokine, Defensin, Peptide synthesis, Gene and Coding region and other disciplines. His CTL* study integrates concerns from other disciplines, such as Cytokine, Genetic enhancement, Telomerase, Stem cell and Telomere. His CD8 study combines topics in areas such as Cellular immunity, Reverse transcriptase and T-cell receptor.
Otto O. Yang focuses on Immunology, Virology, CTL*, Cytotoxic T cell and CD8. His study in Immune system, Viremia, T cell, T lymphocyte and Antigen falls within the category of Immunology. His work deals with themes such as Epitope, Antibody and Human leukocyte antigen, which intersect with Virology.
His research in Epitope intersects with topics in Molecular biology and T-cell receptor. The various areas that Otto O. Yang examines in his CTL* study include Cellular immunity, Immunodominance, Major histocompatibility complex and In vivo. His Cytotoxic T cell research integrates issues from Stem cell and Avidity.
His main research concerns Immunology, Virology, CD8, Cytotoxic T cell and CTL*. His study in Senescence extends to Immunology with its themes. His research on Virology focuses in particular on Viral replication.
His CD8 research is multidisciplinary, incorporating elements of Viremia, Seroconversion, Neutralizing antibody and Vaccination. His work carried out in the field of Cytotoxic T cell brings together such families of science as Stimulation, Gene expression and Immune system. He has included themes like Cytokine secretion, Cytokine, Apoptosis, Avidity and Epitope in his CTL* study.
Otto O. Yang mainly investigates Immunology, Virology, CD8, Viral replication and CTL*. His Immunology research includes elements of Medical record and CD38. His Virology research incorporates elements of Antibody and Pneumonia.
His study looks at the relationship between CD8 and fields such as Cytotoxic T cell, as well as how they intersect with chemical problems. Viral replication is a subfield of Virus that Otto O. Yang investigates. His study in CTL* is interdisciplinary in nature, drawing from both Epitope and Major histocompatibility complex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Hydrodynamic stretching of single cells for large population mechanical phenotyping
Daniel R. Gossett;Henry T. K. Tse;Serena A. Lee;Yong Ying.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo;Jennifer A. Fulcher;David Goodman-Meza;Julie Elliott.
The New England Journal of Medicine (2020)
Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.
O O Yang;S A Kalams;A Trocha;H Cao.
Journal of Virology (1997)
Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1
Alexander M. Cole;Teresa Hong;Lee Ming Boo;Tung Nguyen.
Proceedings of the National Academy of Sciences of the United States of America (2002)
β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
Ludwig Wagner;Otto O. Yang;Eduardo A. Garcia-Zepeda;Yimin Ge.
Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.
Jonah B. Sacha;Chungwon Chung;Eva G. Rakasz;Sean P. Spencer.
Journal of Immunology (2007)
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
O O Yang;S A Kalams;M Rosenzweig;A Trocha.
Journal of Virology (1996)
Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
Fabio Candotti;Kit L. Shaw;Linda Muul;Denise Carbonaro.
Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication
Yang Liu;Juanjuan Du;Ming Yan;Mo Yin Lau.
Nature Nanotechnology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: